| 000 | 01611 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514073527.0 | ||
| 264 | 0 | _c20031118 | |
| 008 | 200311s 0 0 eng d | ||
| 022 | _a0169-5002 | ||
| 024 | 7 |
_a10.1016/s0169-5002(03)00161-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBunn, Paul A | |
| 245 | 0 | 0 |
_aOngoing and future trials of biologic therapies in lung cancer. _h[electronic resource] |
| 260 |
_bLung cancer (Amsterdam, Netherlands) _cAug 2003 |
||
| 300 |
_aS175-86 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aCarcinoma, Small Cell _xdrug therapy |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aShepherd, Frances A | |
| 700 | 1 | _aSandler, Alan | |
| 700 | 1 | _aLe Chevalier, Thierry | |
| 700 | 1 | _aBelani, Chandra P | |
| 700 | 1 | _aKosmidis, Paris A | |
| 700 | 1 | _aScagliotti, Giorgio V | |
| 700 | 1 | _aGiaccone, Giuseppe | |
| 773 | 0 |
_tLung cancer (Amsterdam, Netherlands) _gvol. 41 Suppl 1 _gp. S175-86 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0169-5002(03)00161-2 _zAvailable from publisher's website |
| 999 |
_c12644907 _d12644907 |
||